The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
The FDA says that food companies will have until Jan. 15, 2027 to stop using the dye. Drugmakers will have an extra year, until January 2028, to comply with the change. Red 3, also known as ...
This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...
Create forms, collect data, and analyse it easily with these platforms. All of the best online form builders we list below make it easy to collect customer feedback and marketing data with forms ...
The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...
The FDA has approved Bristol Myers Squibb’s (BMS ... RCC accounts for approximately nine out of 10 kidney cancer diagnoses, making it the most common form. In turn, eight out of 10 RCC diagnoses are ...
Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...
After a priority review, the FDA did not approve an injectable form of Rybrevant, a Johnson & Johnson medication for non-small cell lung cancer. The rejection is not due to the therapy's ...
The new injectable form is expected to be more convenient for patients and could help shield the company from erosion of sales when the patent for the intravenous version expires later this decade.
Meghna Hugo is a responsive, minimalist, lightweight, and fast loading one-page business theme built with HTML5/CSS3, Hugo, JavaScript, and JQuery.